Jasdeep Singh

University of Denver

H指数:16

被引数:1,223

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cofactor-Free Serial Amplification of Tau Filaments from Alzheimer’s Disease and Other Tauopathies Depends on the Conformational State of Tau Monomers

辅因子自由条件下，阿尔茨海默病及其他tau蛋白病的Tau丝状物的串联放大取决于Tau单体的构象状态

JACS Au

IF8.7

2026-03-110

Automated Detection and Diagnosis of Bacterial Skin Infections using Deep Learning with Segmentation Techniques

基于深度学习和分割技术的细菌性皮肤感染自动化检测与诊断

Cognitive Computation

IF4.3

2025-12-260

PRE

Conservation of Putative Liquid-Liquid Phase Separating Proteins in Multiple Drug-Resistant Mycobacterium tuberculosis: Role in Host-Pathogen Interactions?

假定的液-液相分离蛋白在多重耐药结核分枝杆菌中的保守性：其在宿主-病原体相互作用中的作用？

ACS INFECTIOUS DISEASES

IF3.8

2025-04-040

PRE

Spike Protein Mutation-Induced Changes in the Kinetic and Thermodynamic Behavior of Its Receptor Binding Domains Explain Their Higher Propensity to Attain Open States in SARS-CoV-2 Variants of Concern

Spike蛋白突变诱导的其受体结合结构域的动力学和热力学行为的变化解释了它们在所关注的SARS-CoV-2变体中获得开放状态的更高倾向

ACS CENTRAL SCIENCE

IF10.4

2023-09-217

OAAI

Evolutionarily conserved heat shock protein, HtpX, as an adjunct target against antibiotic-resistant Neisseria gonorrhoeae

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2023-08-110

PRE

Polypharmacological repurposing approach identifies approved drugs as potential inhibitors of Mycobacterium tuberculosis

BIOCHEMICAL JOURNAL

IF4.3

2023-07-176

Mycobacterium tuberculosis protein MoxR1 enhances virulence by inhibiting host cell death pathways and disrupting cellular bioenergetics

VIRULENCE

IF5.4

2023-02-2613

OAAI

Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges

SARS-CoV-2的演变: BA.4/BA.5变体继续构成新的挑战

VIRUSES-BASEL

IF3.5

2022-11-237

OAAI

Glycosylation of a key cubilin Asn residue results in reduced binding to albumin

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2022-10-010

OAAI

Antimicrobial-resistant Neisseria gonorrhoeae can be targeted using inhibitors against evolutionary conservedl-asparaginase

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2022-05-086

PRE

Mycobacterium tuberculosis Protein PE6 (Rv0335c), a Novel TLR4 Agonist, Evokes an Inflammatory Response and Modulates the Cell Death Pathways in Macrophages to Enhance Intracellular Survival

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-07-1250

OAAI

SARS-CoV-2 variants of concern are emerging in India

NATURE MEDICINE

IF50

2021-05-27258

PREAI

Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications

VIRUSES-BASEL

IF3.5

2021-03-09103

OAAI

Mycobacterium tuberculosis RipA Dampens TLR4-Mediated Host Protective Response Using a Multi-Pronged Approach Involving Autophagy, Apoptosis, Metabolic Repurposing, and Immune Modulation

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-03-0452

OAAI

Two parallel pandemics: the challenges faced by countries with COVID-19 and TB

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

IF3.1

2020-12-019

PRE

In-silico and biophysical investigation of biomolecular interaction between naringin and nsP2 of the chikungunya virus

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2020-10-014

PREAI

Prion protein transcription is auto-regulated through dynamic interactions with G-quadruplex motifs in its own promoter

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS

IF3.1

2020-03-018

PREAI

Application of a protein domain as chaperone for enhancing biological activity and stability of other proteins

JOURNAL OF BIOTECHNOLOGY

IF3.9

2020-02-013

PREAI

Identification and validation of l-asparaginase as a potential metabolic target against Mycobacterium tuberculosis

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2018-09-1913

OAAI

L-Asparaginase of Leishmania donovani: Metabolic target and its role in Amphotericin B resistance

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE

IF3.4

2017-12-0119

OAAI

Jasdeep Singh

个人简介

教育背景

工作经历

荣誉奖项

研究方向